Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination drug consisting of lidocaine, vitamin B12 (commonly as cyanocobalamin or methylcobalamin), and betamethasone. Lidocaine is a local anesthetic that works by blocking sodium channels, thereby inhibiting nerve signal transmission and providing pain relief. Vitamin B12 is an essential water-soluble vitamin involved in DNA synthesis, myelin formation, and cellular metabolism; it has been studied for its potential analgesic effects in neuropathic pain conditions. Betamethasone is a potent synthetic glucocorticoid corticosteroid with anti-inflammatory and immunosuppressive properties; it acts by binding to the glucocorticoid receptor to modulate gene expression and suppress pro-inflammatory mediators. This combination has been used via local injection (intra-articular or subcutaneous) for the management of various pain syndromes such as acute herpetic neuralgia and knee osteoarthritis. Clinical studies suggest that this combination can reduce inflammatory markers (e.g., IL-1, MMP-3), increase TIMP-1 levels, relieve pain intensity, improve quality of life scores, and potentially lower the incidence of postherpetic neuralgia when administered early after symptom onset[2][3]. The rationale behind combining these agents lies in their complementary mechanisms—local anesthesia from lidocaine for immediate relief; anti-inflammatory action from betamethasone; neurotrophic support from vitamin B12.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lidocaine + vitamin B12 + betamethasone.